.jpg)
.jpg)
WuXi AppTec sees revenue growth after 2024’s decline
WuXi AppTec’s revenue rose for the first few months of 2025, signaling that pressures from the proposed Biosecure Act may be subsiding even as the threat of pharma tariffs remains. The CDMO pulled in 21 ...
WuXi AppTec’s revenue rose for the first few months of 2025, signaling that pressures from the proposed Biosecure Act may be subsiding even as the threat of pharma tariffs remains.
The CDMO pulled in 21 ...
